{
    "type": "ETF",
    "ucits": true,
    "replication_method": "synthetic",
    "leverage": false,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "complex_factors": [
        "Synthetic replication using swaps",
        "Counterparty risk exposure",
        "Use of OTC derivatives"
    ],
    "classification": "complex",
    "supporting_data": "The ETF uses synthetic replication via an over-the-counter swap contract with counterparties like Morgan Stanley and Societe Generale. While the swap is likely unfunded (as is typical for UCITS-compliant synthetic ETFs), the presence of counterparty risk and derivative exposure triggers MiFID II complexity classification. The fact sheet confirms the use of an OTC swap, which is a key complexity indicator. While the ETF tracks a straightforward equity index (MSCI World Financials), the synthetic structure and counterparty risk make it complex under MiFID II rules. The fund's risk profile is primarily market risk, but the derivative-based replication method introduces additional risks (counterparty, liquidity) that may not be easily understood by retail investors. The UCITS compliance does not automatically exempt it from complexity classification when derivatives are used for replication rather than risk management.",
    "confidence": 90
}